Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

Q3 2015

GCVRZ Guru Trades in Q3 2015

Michael Price 1,323,043 sh (+3.77%)
Paul Singer 19,791,100 sh (+3.11%)
Murray Stahl 15,940 sh (unchged)
First Eagle Investment 146,402 sh (unchged)
Mario Gabelli 71,900 sh (-0.28%)
Louis Moore Bacon 745,100 sh (-24.75%)
» More
Q4 2015

GCVRZ Guru Trades in Q4 2015

Michael Price 1,696,993 sh (+28.26%)
Paul Singer 20,454,561 sh (+3.35%)
Murray Stahl 15,940 sh (unchged)
First Eagle Investment 146,402 sh (unchged)
Louis Moore Bacon 745,100 sh (unchged)
Mario Gabelli 65,900 sh (-8.34%)
» More
Q1 2016

GCVRZ Guru Trades in Q1 2016

Michael Price 3,583,668 sh (+111.18%)
First Eagle Investment 146,402 sh (unchged)
Murray Stahl 15,940 sh (unchged)
Louis Moore Bacon 745,100 sh (unchged)
Paul Singer 20,454,561 sh (unchged)
Mario Gabelli 65,100 sh (-1.21%)
» More
Q2 2016

GCVRZ Guru Trades in Q2 2016

Paul Singer 20,454,561 sh (unchged)
Louis Moore Bacon 745,100 sh (unchged)
Michael Price 3,583,668 sh (unchged)
Mario Gabelli 65,100 sh (unchged)
First Eagle Investment 146,402 sh (unchged)
Murray Stahl 15,940 sh (unchged)
» More

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

More Statistics

Short Percentage of Float0.00%
52-Week Range $0.08 - 0.29
» More Articles for GCVRZ

Headlines

Articles On GuruFocus.com
Software Companies Show High Value Potential Sep 29 2016 
Third Avenue Value Fund Reduces Masco Stake Sep 29 2016 
Carl Icahn Clears More Oil Out of Portfolio With Transocean Sell Sep 29 2016 
Deutsche Bank's Losses Affecting the Market on Thursday Sep 29 2016 
What I Learned From Larry Ellison Sep 29 2016 
Natus Medical CEO Acquires Shares in Company Sep 29 2016 
Sears Holdings' Spin-Off Seritage Can Develop Land Sep 29 2016 
12 Questions With Validea Capital Management John Reese Sep 29 2016 
Domino’s Not a Great Buy at This Point Sep 29 2016 
Walmart’s Flipkart Investment Sep 29 2016 

More From Other Websites
Sanofi gets shot in the arm from dollar strength Feb 09 2016
Europe close: Bank stocks lead losses again Feb 09 2016
Europe open: Equity markets in the red as bank stocks weigh Feb 09 2016
Europe midday: Stocks on the back foot as investors remain cautious Feb 08 2016
EU drugs agency sets up Zika task force to speed vaccine work Feb 08 2016
Quest for Zika vaccine widens; Africa, Asia deemed vulnerable Feb 02 2016
France's Sanofi launches Zika virus vaccine research Feb 02 2016
Sanofi launches hunt for Zika vaccine as disease fears grow Feb 02 2016
Zika virus set to spread across Americas, spurring vaccine hunt Jan 25 2016
New Redx director brings scientific, commercial expertise Jan 04 2016
Philippines is first Asian country to approve dengue vaccine Dec 22 2015
GlaxoSmithKline buys Bristol-Myers Squibb HIV assets for up to $1.46bn Dec 18 2015
AstraZeneca buys majority stake in blood cancer specialist Acerta for £2.68bn Dec 17 2015
Aspirin maker Bayer seeks to flex muscles in OTC sector Dec 16 2015
AstraZeneca to buy Takeda's lung business for £383m Dec 16 2015
Commodities stocks help European equities to end sharply higher Dec 15 2015
Commodities stocks help European equities to bounce back Dec 15 2015
Sanofi aims for top spot in consumer health via asset swap Dec 15 2015
Drugs giants Sanofi and Boehringer Ingelheim in talks to exchange £13.2bn of assets Dec 15 2015
European shares boosted by progress in Paris Dec 15 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK